Chris Ford, Senior Vice President, Translational Biology at Seres Therapeutics, discusses the development of SER-155, a cultivated bacterial consortium designed to address the unmet medical need of preventing bloodstream infections…
By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.
Specific microbial metabolites can lead to new therapies for skin barrier disorders such as eczema and psoriasis.
A comprehensive look at the gut microbiome’s structure, functions, and strategies for sustaining its health.
The discussion with Professor Alessio Fasano highlights the complex interplay between homeostatic, hedonic, and microbiota-driven mechanisms in regulating hunger.
Chemical biology offers useful methods to study microbial systems and gather molecular information about microbiomes.
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
Fecal Microbiota Transplantation (FMT) showing promise beyond C. difficile infection in conditions like IBD, IBS, and metabolic disorders.
Celine Druart, from the Pharmabiotic Research Institute, highlighted critical challenges in the microbiome field, particularly around the standardization of clinical protocols and analytical methods.
High levels of bile acids drive bacterial colonization of the gut and exacerbate gut inflammation by altering the intestinal environment.
